Drano: Any visit to the swamp leaves me wanting to take a
Drano: Any visit to the swamp leaves me wanting to take a shower. Thankfully I am able to recognize the liars and understand that they are being paid to try and separate innocent investors from their hard earned money. I feel bad for these folks who have such little self respect they lie for a living 24/7 365 days a year. Imagine when asked their response as to what they do for a living? What do they tell family and what will they tell them when that inevitable knock on the door arrives and they are led away in cuffs? They must feel trapped in order to continue doing what they do. If they were smart they would file as a whisteblower and expose the whole scam that is the path they chose to follow.
We are fortunate here because CTIX has the science and the science will overcome the manipulators and the manipulators will pay dearly for having attacked CTIX. In the meantime there are some things we can do to make things more difficult for our enemy. We can put in GTC sell orders for part or all of our shares at what today are high prices. There is risk in doing this however as once Leo is able to announce the right news the demand for shares will cause them to rise dramatically in price so you must be able to monitor to remove the sell order or you could lose your shares. If you choose to do this place the GTC sell price at a price where you would not mind losing some of your position otherwise you are at risk.
Have an annual physical scheduled soon? Tell you Doctor about CTIX and its science and if you are of a mind bring a brief summary to give him.
With CTIX's science and the drugs in trials there is little risk to any funds he chooses to invest imho.
Last but not least is there one poster who really makes you angry reading his posts? If so print a couple out that really get your motor running and keep those posts nearby so that when the time comes and the shorts keep increasing the bid and begging us to sell them back some markers reading those posts will firm your resolve to make the SOB's pay dearly for their lies and trying to steal your funds. Go CTIX!!!
3
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Decoding the RNA Revolution Ever heard of circular RNA (circRNA)? This ain't your typical strand of genetic code. Unlike their straight-laced, linear counterparts, these RNAs form a loop you can't just break. Picture them as the Kevlar vests of the RNA world—tough, resilient, and packing the promise of next-gen treatments in their covalent loops. Here we’ve got...
Continue Reading
Legal Clouds Over Supernova's SPAC Adventure Alright, folks, buckle up, because whenever you mix SPACs and lawsuits, you're in for a roller coaster. Supernova Partners Acquisition Company, Inc. stands right at the heart of a class action lawsuit, and it's been cooking ever since the court in Delaware gave it a nudge forward. Settlement Talk: What's on the Table? So here's...
Continue Reading
Withings Joins Forces with French Basketball Elite When it comes to linking technology and sports, nothing quite shows promise like Withings teaming up with the French Basketball Federation (FFBB). Picture this: a French startup that's crafted its legacy on cutting-edge health tech now throws its lot in with a nation proud of its basketball prowess. It's the kind of...
Continue Reading
Every now and again, a player like China Southern Power Grid steps up, making waves in the vast energy sea of the Asia-Pacific. The power company's latest foray, showcased at the Asia-Pacific Media Forum in Shenzhen, underscores its ambitions to beef up regional energy connectivity. Asia-Pacific's Hungry Energy Machine The Asia-Pacific region is no lightweight when it...
Continue Reading
SKF's Extraordinary Meeting: A Pivotal Moment AB SKF, a heavyweight in the industrial technology sector, is summoning its shareholders for an Extraordinary General Meeting on October 1, 2026. The venue? The Elite Park Avenue Hotel in Gothenburg, Sweden—sounds fancy, but don't expect to hear a string quartet at this shindig. What's truly on the agenda is a critical...
Continue Reading
KuCoin's Bold Move with KCUSD Folks, the cat's outta the bag with KuCoin's latest maneuver—introducing KCUSD. At first glance, it seems like they're just introducing another fancy stablecoin product, but peel the onion and there's more to it. We're talking about shaking up how stablecoins sit tight doing nada in the crypto world. KCUSD is out to make those idle balances...
Continue Reading
Science and Technology at the Forefront Saturday nights usually have folks kicking back with some reality shows or maybe cheering on their favorite sports team. But this September 12, savvy viewers have a chance to dive deep into the guts of cutting-edge science and tech on Bloomberg Television. We're talking about 'Advancements with Ted Danson'—where science isn’t...
Continue Reading
Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...
Continue Reading
Rising Threats and New Solutions in CABP Market Listen up, folks. The community-acquired bacterial pneumonia (CABP) market is set to swell. And why is that? Well, it's got everything to do with a growing disease burden, aging populations, and complications from comorbid conditions. But here's the kicker: antimicrobial resistance is climbing like a cat up a tree, and that...
Continue Reading
AI Transformation: Hard Reality or Strategic Opportunity? The future of work. That’s what everyone’s buzzing about lately, isn’t it? AI poised to shake every nook and cranny. You're either riding the wave or getting crushed by it. It’s no longer some distant prospect—the challenge is right here, now. Come September 23, Zellis Connect 2026 is plunging headfirst...
Continue Reading
Top 5 Most Recently Viewed Articles
Parse Biosciences Achieves Major Patent Invalidation Against 10x Genomics In a noteworthy development in the biotechnology sector, Parse Biosciences has successfully invalidated key patent claims asserted by 10x Genomics. The Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office rendered Final Written Decisions nullifying all claims...
Continue Reading
Current Market Sentiment for SLM SLM Corp (NYSE: SLM) has become a focal point for investors recently, particularly as the short percent of float has increased to 18.42% since the last reporting period. This percentage translates to a significant 8.78 million shares sold short, representing about 4.95% of all available shares for trading. Given the recent trading...
Continue Reading
Innovative Features of FieldShield Version 6 Recently, Innovative Routines International (NASDAQ: IRI) has introduced a notable update to its acclaimed FieldShield data masking tool. This version marks a significant improvement over previous iterations, particularly in its data classification and discovery functionalities. Since its inception in 2011, FieldShield has been...
Continue Reading
BellRing Brands to Host Fourth Quarter Conference Call BellRing Brands, Inc. (NYSE: BRBR) has announced its plans to hold an informative conference call aimed at discussing its financial results for the fourth quarter and the fiscal year 2024. This call is set for a morning session at nine o'clock on Tuesday and will be led by key executives including Darcy H. Davenport,...
Continue Reading
AECI Limited Announces CFO Resignation AECI Limited has confirmed that Ms. Rochelle Gabriels, the company's Chief Financial Officer, will resign from her role effective December 31, 2024. This important announcement comes as AECI continues to adapt to the dynamic landscape of the chemical and mining industries. Appointment of Interim CFO To ensure a smooth transition and...
Continue Reading